A phase II study of antiangiogenic therapy (Apatinib) plus chemotherapy as second‐line treatment in advanced small cell lung cancer by Yinghui Xu, Xu Wang, Chao Sun, Zhiru Gao, Hua He, Shi Qiu, Ye Guo, Xiaohui Ma, Junya Song, Kewei Ma

Get full text

Updated overall survival data and predictive biomarkers of autologous NK cells plus Sintilimab as second-line treatment for advanced non-small cell lung cancer by Lin Jia, Naifei Chen, Xiao Chen, Chao Niu, Ziling Liu, Kewei Ma, Lei Yang, Yuguang Zhao, Wei Song, Jin Lu, Chen Chen, Xiaofeng Cong, Xu Wang, Yinghui Xu, Guozhen Cui, Zengguang Liu, Rongrong Chen, Huan Yin, Na Zhang, Jiuwei Cui

Get full text

Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population by Liqun Zhou, Kaiwei Yang, Xuesong Li, Yi Ding, Dawei Mu, Hanzhong Li, Yong Yan, Jinyi Li, Dongwen Wang, Wei Li, Yulong Cong, Jiangping Gao, Kewei Ma, Yajun Xiao, Sheng Zhang, Hongyi Jiang, Weilie Hu, Qiang Wei, Xunbo Jin, Zhichen Guan, Qingyong Liu, Danfeng Xu, Xin Gao, Yongguang Jiang, Weimin Gan, Guang Sun, Qing Wang, Yanhui Liu, Jianquan Hou, Liping Xie, Xishuang Song, Fengshuo Jin, Jiafu Feng, Ming Cai, Zhaozhao Liang, Jie Zhang, Dingwei Ye, Lin Qi, Lulin Ma, Jianzhong Shou, Yuping Dai, Jianyong Shao, Ye Tian, Shizhe Hong, Tao Xu, Chuize Kong, Zefeng Kang, Yuexin Liu, Xun Qu, Benkang Shi, Shaobin Zheng, Yi Lin, Shujie Xia, Dong Wei, Jianbo Wu, Weiling Fu, Zhiping Wang, Jianbo Liang

Get full text